Calgary Parkinson Research Initiative (CaPRI)

Summary

CaPRI is an observational study over a ten-year period. The purpose of this study is to create a Registry and Database that furthers our understanding about Parkinson’s disease (PD) and related movement disorders. The information collected will help doctors, researchers, and patients better understand how PD affects patients over time and also enable researchers to develop tests to diagnose and improve treatments for people with PD. CaPRI also aims to facilitate contact between ongoing research studies and participants who wish to contribute to the development and improvement of treatments for PD. Recently, CaPRI has partnered with the Canadian Open Parkinson Network (C-OPN) to expand its research potential Canada wide.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Accepts healthy participants: Yes

Inclusion criteria:

1. Patients diagnosed with Parkinson's disease or Atypical Parkinsonism of any age
2. Healthy controls aged 35 years and over

Exclusion criteria:

1. There are no exclusion criteria for patients with PD or AP in this study
2. Healthy controls cannot have a diagnosis of any neurodegenerative disorder.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Parisa Alizadeh p: 403-220-7148 e: parisa.alizadeh@ucalgary.ca

Principal investigator:

Davide Martino

Clinical trial:

No

REB-ID:

REB16-0545

External links

CaPRI